Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c
Tweet
Share
E-mailGet Alerts CDTX Hot Sheet
Join SI Premium – FREE
Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Volkswagen AG (VOW:GR) (VWAGY) to Hold
- Rothschild Redburn Starts Hut 8 Mining Corp. (HUT) at Neutral
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
